Properties
                                        
                            Description
                            Cobimetinib hemifumarate prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
                         
                                                                            
                                                            
                            Molecular Formula
                            C25H25F3IN3O6
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            Cobimetinib hemifumarate can be used to study the inhibition of MEK1/2 in oncological research.